Actor's Diabetes Linked to Unprescribed Bodybuilding Drugs

A 35-year-old Mumbai film actor recently developed Type 2 diabetes due to unprescribed bodybuilding drugs. For over two years, he injected a cocktail of tamoxifen, growth hormone products, and the experimental peptide MOTS-c, sourced from gym networks. These substances, particularly peptides, elevated growth hormones and interfered with insulin function, causing insulin resistance. Doctors report a growing trend of men and women in their 20s and 30s using unregulated peptides and steroids for rapid physical changes, largely driven by social media pressures. These compounds, like MOTS-c and tamoxifen, are not approved for clinical use in bodybuilding and can disrupt bodily systems unpredictably. Growth hormone compounds, often of unknown purity and dosage, can lead to serious endocrine disruption. The misuse of peptides like BPC-157 and Thymosin Beta-4 is rampant despite limited human clinical data. Users often rely on anecdotal advice from social media, increasing risks of contamination and unforeseen interactions. Influencers promote experimental substances as lifestyle products, creating an informal supply chain outside regulatory oversight. This practice can cost thousands monthly and lead to severe health issues, including hormonal imbalances and deep vein thrombosis. The success of approved GLP1 drugs for weight loss has led to the dangerous generalization that other unapproved peptides offer similar benefits, despite lacking scientific backing and long-term safety data. This trend reflects societal pressure to conform to unrealistic body standards amplified by global beauty standards and social media.